Braveheart Bio

BRVENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.204 B

$30.00 +0.67%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#105SELLAS Life Sciences GroupSLS$2.23B
#106BiohavenBHVN$2.21B
#107Braveheart BioBRVE$2.20B
#108HUTCHMED (China)HCM$2.18B
#109Rapport TherapeuticsRAPP$2.18B

Where these numbers come from

Share counts and financials for Braveheart Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.